DEA Data Shows Marijuana Legalization Linked To ‘Reductions In Opioid Demand,’ New Study Finds

DEA Data Shows Marijuana Legalization Linked To ‘Reductions In Opioid Demand,’ New Study Finds
MJ moment

State-level marijuana legalization is associated with significant reductions in prescribing of the opioid codeine, according to a new study that leverages data from the federal Drug Enforcement Administration (DEA). The paper, published last week in the journal Health Economics, looked at data on prescription opioid shipments in 11 states that legalized cannabis for adult use between 2010-2019, comparing them to prohibitionist states. It found that recreational legalization is linked to a “26 percent reduction in retail pharmacy-based codeine distribution.” The researchers from Cornell University, George Mason University, the University of Georgia and the University of Pittsburgh said that the same trend wasn’t observed for other opioids like hydrocodone and morphine, or shipments to hospitals where there tend to be more stringent prescribing policies. However, the “finding is suggestive that [recreational legalization] may help achieve reductions in opioid misuse, as codeine is a lower-potency opioid with high potential for misuse,” the study found. “Collectively, our findings are consistent with the hypothesis that reductions in opioid demand affected by [recreational cannabis laws], unlike [medical cannabis laws], may be evidence of decreased opioid misuse more than decreased use of prescription opioids to manage chronic pain,” the study authors wrote. One way that this research article is unique is that its “primary data source” was DEA’s Automation of Reports and Consolidation Orders System (ARCOS). “We are the first study, to our knowledge, to leverage ARCOS data which details distribution by endpoint—pharmacies, hospitals, specialists, and narcotic treatment programs—to study the effects of” recreational legalization, the authors wrote. They further said that the effect of legalization on codeine prescribing became more pronounced over years, “increasing from -17.5 percent one year after RCL implementation to -37.3 percent four years after implementation.” “That our findings suggest RCLs affect a reduction specifically in codeine distribution is of particular interest…

Excerpt only …
READ MORE BELOW
Source : DEA Data Shows Marijuana Legalization Linked To ‘Reductions In Opioid Demand,’ New Study Finds

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.